Inogen Inc

INGN Nasdaq CIK: 0001294133

Company Information

Industry Orthopedic, Prosthetic & Surgical Appliances & Supplies
SIC Code 3842
Entity Type operating
SEC Category Accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 500 CUMMINGS CENTER, BEVERLY, MA, 01915
Mailing Address 500 CUMMINGS CENTER, BEVERLY, MA, 01915
Phone 805-562-0500
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 6, 2026 View on SEC
8-K Current report of material events March 30, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
10-K Annual financial report February 27, 2026 View on SEC

Annual Reports

10-K February 27, 2026
  • Inogen Inc. achieved 8% year-over-year revenue growth to $425 million in 2025, driven by strong direct-to-consumer and international B2B sales.
  • The company strategically acquired PhysioAssist Sas for $40 million, expanding its product portfolio and strengthening its European market presence.
View Analysis

Material Events

8-K Leadership Change March 30, 2026
High Impact
  • Strategic leadership overhaul signaling a shift from survival to growth mode.
  • Targeting at least one new product launch per year to drive innovation.
View Analysis
8-K Other January 12, 2026
Medium Impact
  • Achieved overall sales growth of 2% in Q4 2025 ($82M) and 4% for the full year 2025 ($349M).
  • Expected to achieve positive Adjusted EBITDA for the full year 2025, signaling improved profitability and cost management.
View Analysis

Related Companies

Companies in the same industry (SIC: 3842)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.